4,065 Shares in HCA Healthcare, Inc. $HCA Purchased by Summit Wealth Group LLC Co.

Summit Wealth Group LLC Co. acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, Holdings Channel reports. The fund acquired 4,065 shares of the company’s stock, valued at approximately $1,898,000.

Several other institutional investors have also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC raised its stake in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its stake in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. raised its stake in HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on HCA shares. Wells Fargo & Company dropped their price objective on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. UBS Group upped their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Sanford C. Bernstein dropped their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research note on Tuesday, April 28th. Royal Bank Of Canada dropped their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Finally, Oppenheimer dropped their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $517.82.

HCA Healthcare Stock Up 0.9%

NYSE HCA opened at $430.11 on Wednesday. The stock has a market cap of $95.42 billion, a PE ratio of 14.79, a P/E/G ratio of 1.35 and a beta of 1.18. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The business has a 50 day moving average price of $485.46 and a two-hundred day moving average price of $486.47.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.